145 related articles for article (PubMed ID: 27993646)
1. The CD24 surface antigen in neural development and disease.
Gilliam DT; Menon V; Bretz NP; Pruszak J
Neurobiol Dis; 2017 Mar; 99():133-144. PubMed ID: 27993646
[TBL] [Abstract][Full Text] [Related]
2. Evidence for cis interaction and cooperative signalling by the heat-stable antigen nectadrin (murine CD24) and the cell adhesion molecule L1 in neurons.
Kadmon G; von Bohlen und Halbach F; Horstkorte R; Eckert M; Altevogt P; Schachner M
Eur J Neurosci; 1995 May; 7(5):993-1004. PubMed ID: 7613634
[TBL] [Abstract][Full Text] [Related]
3. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells.
Pruszak J; Ludwig W; Blak A; Alavian K; Isacson O
Stem Cells; 2009 Dec; 27(12):2928-40. PubMed ID: 19725119
[TBL] [Abstract][Full Text] [Related]
4. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy.
Eyvazi S; Kazemi B; Dastmalchi S; Bandehpour M
Curr Cancer Drug Targets; 2018; 18(4):328-336. PubMed ID: 28820056
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD24 as a novel immunotherapy for solid cancers.
Yang Y; Zhu G; Yang L; Yang Y
Cell Commun Signal; 2023 Nov; 21(1):312. PubMed ID: 37919766
[TBL] [Abstract][Full Text] [Related]
7. CD24 expression on human keratinocytes.
Redondo P; García-Foncillas J; Okroujnov I; de Felipe I; Quintanilla E
Exp Dermatol; 1998 Aug; 7(4):175-8. PubMed ID: 9758414
[TBL] [Abstract][Full Text] [Related]
8. From mechanism to therapy: the journey of CD24 in cancer.
Zhao K; Wu C; Li X; Niu M; Wu D; Cui X; Zhao H
Front Immunol; 2024; 15():1401528. PubMed ID: 38881902
[TBL] [Abstract][Full Text] [Related]
9. Membranous CD24 drives the epithelial phenotype of pancreatic cancer.
Lubeseder-Martellato C; Hidalgo-Sastre A; Hartmann C; Alexandrow K; Kamyabi-Moghaddam Z; Sipos B; Wirth M; Neff F; Reichert M; Heid I; Schneider G; Braren R; Schmid RM; Siveke JT
Oncotarget; 2016 Aug; 7(31):49156-49168. PubMed ID: 27203385
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into the function of CD24: A driving force in cancer.
Altevogt P; Sammar M; Hüser L; Kristiansen G
Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
[TBL] [Abstract][Full Text] [Related]
11. CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Tan Y; Zhao M; Xiang B; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Feb; 50(1):70-83. PubMed ID: 25666875
[TBL] [Abstract][Full Text] [Related]
12. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas.
Jackson D; Waibel R; Weber E; Bell J; Stahel RA
Cancer Res; 1992 Oct; 52(19):5264-70. PubMed ID: 1327504
[TBL] [Abstract][Full Text] [Related]
13. ABCA2 is a marker of neural progenitors and neuronal subsets in the adult rodent brain.
Broccardo C; Nieoullon V; Amin R; Masmejean F; Carta S; Tassi S; Pophillat M; Rubartelli A; Pierres M; Rougon G; Nieoullon A; Chazal G; Chimini G
J Neurochem; 2006 Apr; 97(2):345-55. PubMed ID: 16539677
[TBL] [Abstract][Full Text] [Related]
14. GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.
Agarwal N; Dancik GM; Goodspeed A; Costello JC; Owens C; Duex JE; Theodorescu D
Cancer Res; 2016 Sep; 76(17):5175-85. PubMed ID: 27312530
[TBL] [Abstract][Full Text] [Related]
15. Antibody-based targeting of CD24 enhances antitumor effect of cetuximab via attenuating phosphorylation of Src/STAT3.
Chen Z; Wang T; Tu X; Xie W; He H; Wang M; Zhang J
Biomed Pharmacother; 2017 Jun; 90():427-436. PubMed ID: 28391164
[TBL] [Abstract][Full Text] [Related]
16. CD24: from A to Z.
Fang X; Zheng P; Tang J; Liu Y
Cell Mol Immunol; 2010 Mar; 7(2):100-3. PubMed ID: 20154703
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis.
Wang Z; Wang Q; Wang Q; Wang Y; Chen J
Int J Biol Markers; 2017 Mar; 32(1):e75-e82. PubMed ID: 27470135
[TBL] [Abstract][Full Text] [Related]
18. [Pilot study on the correlation between high incidence of CD44+/CD24 -/low/ABCG2- cells and poor prognosis in breast cancer].
Gong JF; Yuan YH; Song GH; Yu J; Han Y; Jia J; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):465-70. PubMed ID: 18931706
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues.
Shirasawa T; Akashi T; Sakamoto K; Takahashi H; Maruyama N; Hirokawa K
Dev Dyn; 1993 Sep; 198(1):1-13. PubMed ID: 8292828
[TBL] [Abstract][Full Text] [Related]
20. CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.
Wang X; Zhang Y; Zhao Y; Liang Y; Xiang C; Zhou H; Zhang H; Zhang Q; Qing H; Jiang B; Xiong H; Peng L
Oncotarget; 2016 Aug; 7(34):55663-55676. PubMed ID: 27494878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
